Via R&D Systems
“Sequencing of SARS-CoV-2 showed that it is ~80% identical to SARS-CoV, the CoV responsible for the SARS pandemic in 2002.1,2 Studies have also shown that it also utilizes the same cell surface receptor as SARS-CoV to gain entry into the host cell, which is Angiotensin-Converting Enzyme 2 (ACE-2). Additionally, the viral spike (S) protein, which binds to ACE-2, needs to be primed by cellular serine proteases such as TMPRSS2.1,3 This preliminary identification and characterization of SARS-CoV-2 was key for the development of detection assays. It will also help hasten the efforts to develop antiviral therapies. However, much still needs to be learned about this virus, its infection and transmission, and the magnitude of COVID-19.”
“As a leading brand in the life sciences industry, Bio-Techne develops resources to support CoV research, including for SARS-CoV-2 detection, cytokine monitoring, and drug discovery, in order to help the scientific community understand the mechanisms of infection and develop effective treatments. Also, if you need something for SARS-CoV-2 research, but can’t find it, or if you need to outsource the production of proteins, antibodies, or immunoassays, contact our Custom Services to find out how we can help you.”
See Bio-Techne’s COVID-19-specific capabilities
MAA COVID-19 INFORMATION DISCLAIMER:
The Medical Alley Association is providing COVID-19 related information, including the “COVID-19 Resource Connect” feature on its website and summaries of laws, executive orders, and government programs that may be of interest to members, as a public service. The Medical Alley Association makes no representations, guarantees, or warranties as to the accuracy, completeness, currency, or suitability of the COVID-19 related information provided by the Medical Alley Association on its website, in newsletters, or in any other communications. The Medical Alley Association specifically disclaims any and all liability for any claims or damages that may result from providing COVID-19 related information online or in other communications or linking to third party websites or other sources of information. The Medical Alley Association makes no effort to independently verify, and does not exert editorial control over, information provided by third parties.
The Medical Alley Association does not endorse any of the products, vendors, consultants, or documentation referenced in, or connected to parties through, the COVID-19 Resource Connect feature or via email or other communications.
